Back to Search
TERESA HUGHES, PHARMD
PHARMD
Pharmacist
NPI: 1215508015Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
P9418(ID)
Research & Publications (20)
Emerging therapies for metabolic diseases--the focus is on diabetes and obesity.
PMID 19482541·Curr Opin Chem Biol·2009
6-review
Clinical strategies to achieve an early and successful response to tyrosine kinase inhibitor therapy.
PMID 19621544·Semin Hematol·2009
8-other
Impact of baseline BCR-ABL mutations on response to nilotinib in patients with chronic myeloid leukemia in chronic phase.
PMID 19652056·J Clin Oncol·2009
3-trial
Impact of early dose intensity on cytogenetic and molecular responses in chronic- phase CML patients receiving 600 mg/day of imatinib as initial therapy.
PMID 18768781·Blood·2008
3-trial
The association between social resources and cognitive change in older adults: evidence from the Charlotte County Healthy Aging Study.
PMID 18689766·J Gerontol B Psychol Sci Soc Sci·2008
8-other
Natural linear-scaled coupled-cluster theory with local transferable triple excitations: applications to peptides.
PMID 18543896·J Phys Chem A·2008
8-other
Is drug treatment superior to allografting as first-line therapy in chronic myeloid leukemia?
PMID 17940526·Nat Clin Pract Oncol·2008
8-other
Transferability in the natural linear-scaled coupled-cluster effective Hamiltonian approach: Applications to dynamic polarizabilities and dispersion coefficients.
PMID 18698886·J Chem Phys·2008
8-other
Strong genetic control of emergence of human primary incisors.
PMID 18037648·J Dent Res·2007
4-observational
ABL kinase inhibitor therapy for CML: baseline assessments and response monitoring.
PMID 17124063·Hematology Am Soc Hematol Educ Program·2006
6-review
Molecular monitoring of BCR-ABL as a guide to clinical management in chronic myeloid leukaemia.
PMID 16426942·Blood Rev·2006
6-review
Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results.
PMID 16522812·Blood·2006
6-review
Underestimation of mortality due to chronic obstructive pulmonary disease (COPD) in Kentucky.
PMID 16939035·J Ky Med Assoc·2006
4-observational
"Fingered" patterns in electron droplets in nonuniform magnetic fields.
PMID 12785969·Phys Rev Lett·2003
8-other
Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia.
PMID 14534335·N Engl J Med·2003
3-trial
A study of occlusal variation in the primary dentition of Australian twins and singletons.
PMID 11420058·Arch Oral Biol·2001
4-observational
Genetic analysis of deciduous tooth size in Australian twins.
PMID 11000386·Arch Oral Biol·2000
4-observational
Fractionated subcutaneous rituximab is well-tolerated and preserves CD20 expression on tumor cells in patients with chronic lymphocytic leukemia.
PMID 19679883·Haematologica·2010
3-trial
Evidence that opioids may have toll-like receptor 4 and MD-2 effects.
PMID 19679181·Brain Behav Immun·2010
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 905 YELLOWSTONE AVE
POCATELLO, ID 83201 - Phone
- (208) 233-2382
Quick Facts
- NPI
- 1215508015
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile